Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q1 2026 Earnings Call Transcript
Operator: Hello. Thank you for standing by, and welcome to Therapeutics First Quarter 26 Conference Call. After the speakers' presentation, there will be a question and answer session. Telephone.





